Rare Cancer Market: A Global Crusade on what is a ‘less common cancer’?
Mar 5, 2021
Cancer is often challenging, however, diagnosis of rare cancer poses extra difficulties. Of all the diagnosed cancers, approximately 22% of the cases are rare cancers. Acco...
Read More
What are the Market Drivers Fueling the Rare Disease Market?
Mar 1, 2021
Rare diseases–also go by the name Orphan diseases–are the conditions that do not affect many individuals out there in one particular geographic area. Going deeper into ...
Read More
Gene and Cell Therapies in CNS Disorders: Miracle Cure? Opportunities Galore!
Feb 26, 2021
CNS disorders are a wide-ranging set of disorders in which the brain loses its normal functioning, limiting everyday ability to function. These may arise from various reaso...
Read More
Clover biopharmaceuticals raises $230 M; BrainStorm after ALS; BARDA grants $5.65 M LightDeck for SARS-CoV-2 antigen test; Libtayo for first-line advanced NSCLC subset
Feb 23, 2021
Clover Biopharmaceuticals Raises $230 Million Clover Biopharmaceuticals announced the completion of an oversubscribed $230 million Series C financing, summing total c...
Read More
Emerging Research Continues To Transform Erythropoietic Protoporphyria Market Outlook
Feb 22, 2021
Lack of knowledge about conditions, situations, or body ailments that are unexplainable often scares people and leads to people jumping to conclusions or say myths that are...
Read More
Hypofibrinogenemia Market: Limited Pipeline Therapies, Abundant Opportunities
Feb 19, 2021
Like troops at the forefront of any battle, our immune system continually marches to protect us from foreign elements and invaders, including bacteria, viruses, and others....
Read More
Merck, Eisai in renal cancer market; G1 Therapeutics on Cosela’s approval; Takeda’s Maribavir; Astellas/Seagen Padcev
Feb 16, 2021
Merck’s Keytruda-Eisai’s Lenvima Combo Make the Cut in Renal Cancer Numerous immunotherapy-based combinations are already trying in the old game of gleek to sta...
Read More
The Paradox of Rare: Chalking out Challenges in the Rare Disease Market
Feb 15, 2021
How is a Rare disease defined? Well, it depends on the geography in question, since there is no universal definition, even so, the definition revolves around the point of p...
Read More
Limited Therapies in the Pipeline: Watch out for Rare Indications that Calls Out for Novel Therapies
Feb 12, 2021
Rare diseases affect a small percent of the population. In the United States, a rare disease is a condition that affects fewer than 200,000 people in the US (Orphan Drug Ac...
Read More
Deerfield/ Dana-Farber’s USD 130 Million Cancer Research Deal; FDA-Approval to BMS’ Breyanzi & TG Therapeutics’ Ukoniq; EU Marketing Rights for ViiV Healthcare’s Rukobia
Feb 9, 2021
Deerfield and Dana-Farber Establish Links in USD 130 Million Cancer Research Deal Deerfield Management has entered into a research agreement with Dana-Farber Cancer I...
Read More
Cystic Fibrosis Market: A Rapidly Expanding Playing Field for Mid-Cap Pharma
Feb 8, 2021
Cystic Fibrosis is a rare inherited disorder that causes loss of lung function and damages the digestive system. It has a higher prevalence in the Caucasian population. For...
Read More
The Mesh of the Generics and the Potential of Emerging Therapies in the Smoking Cessation Market
Feb 5, 2021
Smoking is the leading preventable cause of death in the world. However, prior to 1900, tobacco smoking was an uncommon sight. It was not until the 20th century that smokin...
Read More
Chronic Refractory Cough Market and the Monopoly of the Over-The-Counter Drugs
Feb 1, 2021
Cough! Cough! Every time something goes down the wrong pipe, we cough it out. Within seconds, it gets normal. We catch flu, or cold, cough accompanies for a week or two. Ho...
Read More
Notorious Hyperkalemia: What are the causes, signs and new treatments?
Jan 29, 2021
Bananas! Mostly everyone loves bananas. Who wouldn’t? They taste good and they are a rich source of potassium. Besides lovely bananas, oranges, cantaloupe, honeydew, apri...
Read More
A Bleak Pipeline and Lack of Approved Treatment Clouds the Hemophagocytic Lymphohistiocytosis Market Size Growth
Jan 25, 2021
Having a strong immune system, flourished with properly working immune cells is the ultimate key to surviving a healthy life. However, what if a person is in possession of ...
Read More
